Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Elanco Animal Health
ELAN
$11.1B
| $20.7M | 0.01% |
1,692,446
+1,309,792
| +342% | +$16.3M |
|
877
DXC Technology
DXC
$1.73B
| $20.7M | 0.01% |
779,520
-438,549
| -36% | -$12.2M |
|
878
Full Truck Alliance
YMM
$9.99B
| $20.6M | 0.01% |
2,580,314
+1,714,592
| +198% | +$11.8M |
|
|
NVEI
879
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $20.6M | 0.01% |
811,244
+791,071
| +3,921% | +$22.4M |
|
|
SYNH
880
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $20.5M | 0.01% |
560,171
+525,043
| +1,495% | +$20.8M |
|
881
Owens Corning
OC
$12.4B
| $20.5M | 0.01% |
240,422
-9,324
| -4% | -$817K |
|
882
Globe Life
GL
$14.3B
| $20.4M | 0.01% |
169,518
+22,071
| +15% | +$2.52M |
|
883
PUT
Philip Morris
PM
$295B
| $20.3M | 0.01% |
201,000
+4,000
| +2% | +$377K |
|
884
PUT
DexCom
DXCM
$32B
| $20.3M | 0.01% |
+179,200
| New | +$19.7M |
|
885
CALL
Antero Resources
AR
$10.7B
| $20.3M | 0.01% |
+653,800
| New | +$22.6M |
|
886
CALL
Trade Desk
TTD
$6.49B
| $20.3M | 0.01% |
+451,900
| New | +$22.9M |
|
887
PUT
Kraft Heinz
KHC
$30B
| $20.2M | 0.01% |
+495,600
| New | +$18.8M |
|
888
Boyd Gaming
BYD
$6.06B
| $20.1M | 0.01% |
369,400
-205,537
| -36% | -$11.6M |
|
889
NNN REIT
NNN
$8.99B
| $20.1M | 0.01% |
438,936
+343,201
| +358% | +$14.9M |
|
890
Snap-on
SNA
$21.5B
| $20M | 0.01% |
87,634
+18,903
| +28% | +$4.27M |
|
891
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $20M | 0.01% |
+240,900
| New | +$19.5M |
|
892
PUT
Under Armour
UAA
$2.6B
| $20M | 0.01% |
+1,963,600
| New | +$17M |
|
|
SJR
893
DELISTED
Shaw Communications Inc.
SJR
| $19.9M | 0.01% |
692,623
+666,866
| +2,589% | +$17.5M |
|
894
PUT
Wayfair
W
$14.6B
| $19.9M | 0.01% |
+603,800
| New | +$21.1M |
|
895
Fair Isaac
FICO
$22.5B
| $19.8M | 0.01% |
33,136
+6,411
| +24% | +$3.37M |
|
|
ENLC
896
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $19.7M | 0.01% |
1,603,452
-117,294
| -7% | -$1.35M |
|
897
CALL
McDonald's
MCD
$195B
| $19.7M | 0.01% |
+74,800
| New | +$19.7M |
|
898
CALL
Snowflake
SNOW
$115B
| $19.7M | 0.01% |
+137,100
| New | +$20.9M |
|
899
PUT
Halliburton
HAL
$26.6B
| $19.7M | 0.01% |
+500,000
| New | +$17.7M |
|
900
Eastman Chemical
EMN
$8.42B
| $19.6M | 0.01% |
241,120
+46,658
| +24% | +$3.76M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.